URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Yuhchyau Chen

Concepts (269)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Carcinoma, Non-Small-Cell Lung
12
2001
71
4.970
Why?
Lung Neoplasms
13
2001
428
4.390
Why?
Reticulocytes
8
2003
46
4.210
Why?
Paclitaxel
6
2001
57
2.370
Why?
Micronuclei, Chromosome-Defective
4
2007
21
2.300
Why?
Radiation-Sensitizing Agents
5
2001
72
2.280
Why?
Radiation Pneumonitis
6
2001
44
1.730
Why?
Neoplasms
8
2003
723
1.610
Why?
Gamma Rays
3
2009
69
1.540
Why?
Thoracic Neoplasms
4
2001
19
1.430
Why?
Antineoplastic Agents, Phytogenic
3
2003
39
1.360
Why?
Bone Marrow Cells
2
2009
223
1.340
Why?
Micronucleus Tests
6
2003
25
1.300
Why?
Flow Cytometry
12
1988
597
1.170
Why?
Dose-Response Relationship, Radiation
9
2003
218
1.040
Why?
Fibroblast Growth Factor 7
2
2011
11
1.040
Why?
Radiation Injuries, Experimental
3
2005
88
0.980
Why?
Whole-Body Irradiation
4
1999
82
0.970
Why?
Interleukin-6
4
2001
340
0.860
Why?
Chemoradiotherapy
1
2012
1
0.840
Why?
Radiation Oncology
2
2006
18
0.830
Why?
Deglutition Disorders
1
2012
17
0.830
Why?
Laryngeal Neoplasms
1
2011
19
0.800
Why?
Middle Aged
22
2001
9877
0.800
Why?
Chromosome Aberrations
3
2003
116
0.780
Why?
Aged
17
2001
7272
0.750
Why?
Taxoids
1
2010
13
0.750
Why?
Radiotherapy
5
2003
198
0.750
Why?
Combined Modality Therapy
5
2003
486
0.750
Why?
Aged, 80 and over
12
2001
2513
0.740
Why?
Cell Cycle
9
1988
248
0.730
Why?
Radiometry
1
2010
40
0.720
Why?
Biological Assay
1
2010
71
0.710
Why?
Radiotherapy Dosage
9
2001
203
0.710
Why?
Adult
22
1988
11345
0.690
Why?
Female
27
1988
19826
0.690
Why?
Pneumonectomy
2
2008
13
0.690
Why?
Carcinoma, Squamous Cell
1
2011
232
0.690
Why?
Neoplastic Stem Cells
1
2009
43
0.680
Why?
Palliative Care
2
2010
159
0.670
Why?
Radiation Injuries
3
2006
130
0.670
Why?
Humans
41
1988
36400
0.660
Why?
Male
24
1988
19713
0.640
Why?
Clinical Trials as Topic
2
2004
675
0.610
Why?
Cesium Radioisotopes
1
2007
29
0.610
Why?
Biological Markers
6
2001
564
0.610
Why?
Biomedical Research
1
2009
140
0.590
Why?
Automation
1
2006
30
0.580
Why?
Treatment Outcome
10
2008
2623
0.580
Why?
Interleukin-1
2
2002
222
0.570
Why?
Nuclear Energy
1
2006
3
0.560
Why?
Radiobiology
1
2006
10
0.550
Why?
International Agencies
1
2006
9
0.550
Why?
Cytokines
3
2002
572
0.490
Why?
Dose Fractionation
4
2009
58
0.450
Why?
Mice
11
1990
6103
0.430
Why?
Antineoplastic Combined Chemotherapy Protocols
3
2009
430
0.420
Why?
Genetic Testing
1
2003
102
0.420
Why?
Drug Administration Schedule
3
2001
369
0.410
Why?
Oxygen
1
2005
500
0.400
Why?
Neoplasm Staging
4
2008
335
0.390
Why?
Neoplasms, Experimental
1
2001
138
0.390
Why?
Platelet-Derived Growth Factor
3
1989
115
0.390
Why?
Epidermal Growth Factor
3
1989
115
0.380
Why?
Bioreactors
2
2009
8
0.370
Why?
Severity of Illness Index
3
2006
919
0.370
Why?
Genetic Predisposition to Disease
1
2003
329
0.370
Why?
Animals
15
1990
16270
0.370
Why?
Somatomedins
2
1989
14
0.370
Why?
Follow-Up Studies
4
2001
1857
0.340
Why?
Insulin-Like Growth Factor I
2
1989
106
0.330
Why?
Head and Neck Neoplasms
2
2007
84
0.330
Why?
Retrospective Studies
6
2008
2260
0.320
Why?
Radiosurgery
2
2009
74
0.310
Why?
Cell Survival
2
1990
561
0.310
Why?
Cells, Cultured
7
1988
2563
0.310
Why?
Antineoplastic Agents
5
2003
625
0.310
Why?
Tumor Necrosis Factor-alpha
2
2001
695
0.300
Why?
DNA Damage
4
2003
167
0.300
Why?
Enzyme-Linked Immunosorbent Assay
3
2001
466
0.290
Why?
Mitosis
2
1990
102
0.290
Why?
Fibroblasts
3
1988
545
0.290
Why?
Cisplatin
3
2009
94
0.270
Why?
Mice, Inbred C57BL
3
2009
1683
0.260
Why?
Survival Rate
4
2009
619
0.260
Why?
Tumor Cells, Cultured
3
2001
863
0.260
Why?
Sensitivity and Specificity
2
2005
905
0.240
Why?
Tumor Markers, Biological
2
2003
228
0.240
Why?
Proportional Hazards Models
3
2008
453
0.240
Why?
Time Factors
5
1989
3201
0.240
Why?
Pyrazoles
2
2003
59
0.230
Why?
Tomography, X-Ray Computed
3
2003
765
0.230
Why?
Receptors, Thrombopoietin
1
2012
10
0.210
Why?
Hydrazines
1
2012
14
0.210
Why?
Benzoates
1
2012
16
0.210
Why?
Survival Analysis
2
2011
598
0.210
Why?
Disease Progression
2
2009
519
0.210
Why?
Double-Blind Method
2
2011
998
0.210
Why?
Carboplatin
1
2012
30
0.210
Why?
Skin
2
1989
381
0.210
Why?
Population
1
2011
10
0.200
Why?
Stomatitis
1
2011
15
0.200
Why?
Thrombocytopenia
1
2012
76
0.200
Why?
Disease-Free Survival
1
2012
202
0.200
Why?
SEER Program
1
2011
52
0.200
Why?
Kaplan-Meier Estimate
1
2012
224
0.190
Why?
Culture Media
2
1988
196
0.190
Why?
Erythroid Cells
1
2011
13
0.190
Why?
Recombinant Proteins
2
2010
768
0.190
Why?
Tumor Stem Cell Assay
1
2010
23
0.190
Why?
Stem Cell Transplantation
1
2012
113
0.190
Why?
Bromodeoxyuridine
4
1988
67
0.190
Why?
Magnetic Resonance Spectroscopy
1
1992
241
0.190
Why?
Erythropoiesis
1
2010
49
0.190
Why?
Granulocyte Colony-Stimulating Factor
1
2010
46
0.190
Why?
Nausea
2
2007
155
0.190
Why?
Remission Induction
1
2010
163
0.180
Why?
Neoplasm Recurrence, Local
2
2009
286
0.180
Why?
Translational Medical Research
1
2010
38
0.180
Why?
Cell Line, Tumor
2
2003
576
0.180
Why?
Neoplastic Cells, Circulating
1
2009
7
0.180
Why?
Radiation Dosage
1
2010
126
0.170
Why?
Information Dissemination
1
2009
24
0.170
Why?
Acupressure
1
2009
16
0.170
Why?
Drug Resistance, Neoplasm
1
2009
56
0.170
Why?
Adrenal Gland Neoplasms
1
2009
36
0.170
Why?
Cell Hypoxia
1
2009
90
0.170
Why?
Pilot Projects
1
2010
441
0.170
Why?
Prospective Studies
2
2001
1677
0.160
Why?
Smoking
2
2008
390
0.160
Why?
Infusions, Intravenous
1
2008
139
0.160
Why?
Quinuclidines
1
2007
5
0.160
Why?
Kinetics
2
1988
1464
0.160
Why?
Muscarinic Agonists
1
2007
21
0.150
Why?
Thiophenes
1
2007
17
0.150
Why?
Cohort Studies
1
2011
969
0.150
Why?
Xerostomia
1
2007
40
0.150
Why?
Hematopoietic Stem Cells
1
2009
190
0.150
Why?
Bisbenzimidazole
3
1988
9
0.150
Why?
Antigens, Differentiation, B-Lymphocyte
2
2003
50
0.140
Why?
Reproducibility of Results
1
2010
884
0.140
Why?
Dictionaries as Topic
1
2006
1
0.140
Why?
Radiation-Protective Agents
1
2006
41
0.130
Why?
Lung
2
1988
1142
0.130
Why?
New York
1
2010
1282
0.130
Why?
Age Factors
1
2009
1121
0.130
Why?
Antigens, CD
2
2003
245
0.130
Why?
Spectroscopy, Near-Infrared
1
2005
12
0.130
Why?
Terminology as Topic
1
2006
107
0.130
Why?
ROC Curve
1
2005
126
0.130
Why?
History, 21st Century
1
2005
48
0.130
Why?
Cell Differentiation
1
2011
1098
0.130
Why?
Intestines
1
2005
151
0.120
Why?
Apoptosis
3
2003
855
0.120
Why?
Research
1
2005
179
0.120
Why?
Anoxia
1
2005
158
0.120
Why?
History, 20th Century
1
2005
243
0.120
Why?
Information Services
1
2003
22
0.110
Why?
Maximum Tolerated Dose
1
2003
18
0.110
Why?
United States
1
2011
2630
0.110
Why?
G2 Phase
1
2003
30
0.110
Why?
Cyclooxygenase Inhibitors
1
2003
66
0.110
Why?
Predictive Value of Tests
1
2005
601
0.110
Why?
Sulfonamides
1
2003
103
0.110
Why?
Surgical Procedures, Operative
1
2003
114
0.110
Why?
Models, Biological
1
2007
1023
0.100
Why?
Transplantation, Heterologous
1
2001
98
0.100
Why?
Necrosis
1
2001
105
0.100
Why?
Neoplasm Transplantation
1
2001
187
0.100
Why?
Mesothelioma
1
2001
27
0.100
Why?
Postoperative Complications
1
2006
743
0.100
Why?
Isoenzymes
1
2003
445
0.090
Why?
Risk Factors
2
2002
2318
0.090
Why?
Transplantation Conditioning
1
1999
31
0.090
Why?
Prognosis
1
2003
1080
0.090
Why?
Cyclophosphamide
1
1999
173
0.080
Why?
Fibroblast Growth Factor 2
1
1999
84
0.080
Why?
Bone Marrow Transplantation
1
1999
186
0.080
Why?
Dose-Response Relationship, Drug
2
1990
1138
0.070
Why?
Comorbidity
2
2008
374
0.070
Why?
Breast Neoplasms
1
2003
675
0.070
Why?
Transplantation, Homologous
2
1999
260
0.070
Why?
Ethidium
1
1994
15
0.060
Why?
Receptors, Transferrin
2
2003
20
0.060
Why?
Staining and Labeling
2
1990
165
0.060
Why?
Platelet Count
1
2012
49
0.050
Why?
Tissue Survival
1
1992
5
0.050
Why?
Phosphocreatine
1
1992
13
0.050
Why?
Hydrogen
1
1992
28
0.050
Why?
Organophosphorus Compounds
1
1992
25
0.050
Why?
Transplantation, Autologous
1
2012
144
0.050
Why?
Fatal Outcome
1
2012
109
0.050
Why?
Models, Anatomic
1
1992
39
0.050
Why?
Phosphorus
1
1992
49
0.050
Why?
Intention to Treat Analysis
1
2011
10
0.050
Why?
Drug Toxicity
1
2011
16
0.050
Why?
Cell Separation
2
1988
227
0.050
Why?
BH3 Interacting Domain Death Agonist Protein
1
2011
10
0.050
Why?
Phosphates
1
1992
154
0.050
Why?
Rats, Inbred F344
1
1992
362
0.050
Why?
Ischemia
1
1992
90
0.050
Why?
Erythroblasts
1
2011
26
0.050
Why?
Diploidy
1
1990
13
0.050
Why?
bcl-2-Associated X Protein
1
2011
56
0.050
Why?
Weight Loss
1
2011
75
0.050
Why?
bcl-X Protein
1
2011
39
0.050
Why?
Rats, Inbred Strains
1
1992
654
0.050
Why?
Equipment Design
1
1992
247
0.050
Why?
Mitogens
1
1990
36
0.050
Why?
Surgical Flaps
1
1992
113
0.050
Why?
Neoplasm Metastasis
1
2011
229
0.050
Why?
Rats
2
1992
4386
0.050
Why?
Image Enhancement
1
1992
146
0.050
Why?
Cell Count
1
1990
286
0.040
Why?
Transferrin
1
1989
37
0.040
Why?
Markov Chains
1
2009
36
0.040
Why?
Etoposide
1
2009
83
0.040
Why?
Cell Communication
1
1990
141
0.040
Why?
Tumor Burden
1
2009
23
0.040
Why?
Recurrence
1
2011
697
0.040
Why?
Gastrointestinal Tract
1
2009
24
0.040
Why?
Cell Division
3
1988
766
0.040
Why?
Fluorescent Dyes
1
1990
232
0.040
Why?
Dexamethasone
1
1989
183
0.040
Why?
Vomiting
1
2009
116
0.040
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2011
543
0.040
Why?
Benzimidazoles
1
1988
23
0.040
Why?
Biopsy
1
1989
359
0.040
Why?
Dyspepsia
1
2007
2
0.040
Why?
Sweat
1
2007
7
0.040
Why?
Diarrhea
1
2007
64
0.040
Why?
Pulmonary Fibrosis
1
1988
140
0.040
Why?
Insulin
1
1990
670
0.040
Why?
Logistic Models
1
2009
578
0.040
Why?
Incidence
1
2008
679
0.030
Why?
Transforming Growth Factor beta2
1
2005
4
0.030
Why?
Transforming Growth Factor beta3
1
2005
4
0.030
Why?
Algorithms
1
2009
537
0.030
Why?
Kidney
1
2009
582
0.030
Why?
Mice, Inbred DBA
1
2005
88
0.030
Why?
Risk Assessment
1
2009
878
0.030
Why?
Gene Expression Regulation
1
2011
875
0.030
Why?
Transforming Growth Factor beta1
1
2005
77
0.030
Why?
DNA
1
1990
856
0.030
Why?
Propidium
1
2004
3
0.030
Why?
Young Adult
1
2009
1074
0.030
Why?
Cytogenetic Analysis
1
2004
21
0.030
Why?
Splenectomy
1
2003
37
0.030
Why?
Splenic Diseases
1
2003
15
0.030
Why?
Antimetabolites, Antineoplastic
1
2004
38
0.030
Why?
Pregnancy
1
1989
1962
0.030
Why?
Drug Screening Assays, Antitumor
1
2003
36
0.030
Why?
Fluorouracil
1
2004
76
0.030
Why?
Xenograft Model Antitumor Assays
1
2003
46
0.030
Why?
Cyclooxygenase 2 Inhibitors
1
2003
64
0.030
Why?
Interferon-gamma
1
2005
345
0.030
Why?
Transforming Growth Factor beta
1
2005
413
0.030
Why?
Cyclooxygenase 2
1
2003
226
0.030
Why?
Prostaglandin-Endoperoxide Synthases
1
2003
169
0.030
Why?
Rats, Sprague-Dawley
1
2004
1028
0.020
Why?
Membrane Proteins
1
2003
553
0.020
Why?
RNA, Messenger
1
2005
1857
0.020
Why?
Data Display
1
1990
13
0.010
Why?
Reference Standards
1
1990
45
0.010
Why?
Fluorescence
1
1990
73
0.010
Why?
Microcomputers
1
1988
10
0.010
Why?
Fluorescent Antibody Technique
1
1988
291
0.010
Why?
Lymphocytes
1
1988
274
0.010
Why?
Lymphocyte Activation
1
1988
402
0.010
Why?

Visualizations


Chen's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department